Thirumalai Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 1, 2025, 9:26 am

Competitors of Thirumalai Chemicals Ltd

All Competitor Stocks of Thirumalai Chemicals Ltd

Quarterly Result

Last Updated: May 31, 2025, 7:31 am

Below is a detailed analysis of the quarterly data for Thirumalai Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 523.00 Cr.. The value appears strong and on an upward trend. It has increased from 447.00 Cr. (Dec 2024) to 523.00 Cr., marking an increase of 76.00 Cr..
• For Expenses, as of Mar 2025, the value is 508.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 467.00 Cr. (Dec 2024) to 508.00 Cr., marking an increase of 41.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from -20.00 Cr. (Dec 2024) to 15.00 Cr., marking an increase of 35.00 Cr..
• For OPM %, as of Mar 2025, the value is 3.00%. The value appears strong and on an upward trend. It has increased from -5.00% (Dec 2024) to 3.00%, marking an increase of 8.00%.
• For Other Income, as of Mar 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Dec 2024) to 8.00 Cr., marking an increase of 8.00 Cr..
• For Interest, as of Mar 2025, the value is 15.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 14.00 Cr. (Dec 2024) to 15.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Mar 2025, the value is 18.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 16.00 Cr. (Dec 2024) to 18.00 Cr., marking an increase of 2.00 Cr..
• For Profit before tax, as of Mar 2025, the value is -11.00 Cr.. The value appears strong and on an upward trend. It has increased from -50.00 Cr. (Dec 2024) to -11.00 Cr., marking an increase of 39.00 Cr..
• For Tax %, as of Mar 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from -16.00% (Dec 2024) to 28.00%, marking an increase of 44.00%.
• For Net Profit, as of Mar 2025, the value is -14.00 Cr.. The value appears strong and on an upward trend. It has increased from -42.00 Cr. (Dec 2024) to -14.00 Cr., marking an increase of 28.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is -1.37. The value appears strong and on an upward trend. It has increased from -4.10 (Dec 2024) to -1.37, marking an increase of 2.73.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:43 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:12 am

Below is a detailed analysis of the balance sheet data for Thirumalai Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,145.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,136.00 Cr. (Mar 2024) to 1,145.00 Cr., marking an increase of 9.00 Cr..
• For Borrowings, as of Mar 2025, the value is 1,786.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 1,252.00 Cr. (Mar 2024) to 1,786.00 Cr., marking an increase of 534.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 865.00 Cr.. The value appears to be improving (decreasing). It has decreased from 922.00 Cr. (Mar 2024) to 865.00 Cr., marking a decrease of 57.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,807.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,320.00 Cr. (Mar 2024) to 3,807.00 Cr., marking an increase of 487.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,251.00 Cr.. The value appears strong and on an upward trend. It has increased from 712.00 Cr. (Mar 2024) to 1,251.00 Cr., marking an increase of 539.00 Cr..
• For CWIP, as of Mar 2025, the value is 1,352.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,200.00 Cr. (Mar 2024) to 1,352.00 Cr., marking an increase of 152.00 Cr..
• For Investments, as of Mar 2025, the value is 200.00 Cr.. The value appears strong and on an upward trend. It has increased from 173.00 Cr. (Mar 2024) to 200.00 Cr., marking an increase of 27.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,004.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,236.00 Cr. (Mar 2024) to 1,004.00 Cr., marking a decrease of 232.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,807.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,320.00 Cr. (Mar 2024) to 3,807.00 Cr., marking an increase of 487.00 Cr..

However, the Borrowings (1,786.00 Cr.) are higher than the Reserves (₹1,145.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Thirumalai Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 5. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
• For Diluted EPS (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 5. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.46. This value is below the healthy minimum of 3. It has decreased from 2.38 (Mar 24) to 1.46, marking a decrease of 0.92.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 112.86. It has increased from 111.93 (Mar 24) to 112.86, marking an increase of 0.93.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 112.86. It has increased from 111.93 (Mar 24) to 112.86, marking an increase of 0.93.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 200.15. It has decreased from 203.43 (Mar 24) to 200.15, marking a decrease of 3.28.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 6.78. This value is within the healthy range. It has decreased from 6.87 (Mar 24) to 6.78, marking a decrease of 0.09.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.81. This value is within the healthy range. It has increased from 0.69 (Mar 24) to 0.81, marking an increase of 0.12.
• For PBT / Share (Rs.), as of Mar 25, the value is -3.99. This value is below the healthy minimum of 0. It has decreased from -3.37 (Mar 24) to -3.99, marking a decrease of 0.62.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 2. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -4.50. This value is below the healthy minimum of 2. It has decreased from -3.79 (Mar 24) to -4.50, marking a decrease of 0.71.
• For PBDIT Margin (%), as of Mar 25, the value is 3.38. This value is below the healthy minimum of 10. It has increased from 3.37 (Mar 24) to 3.38, marking an increase of 0.01.
• For PBIT Margin (%), as of Mar 25, the value is 0.40. This value is below the healthy minimum of 10. It has increased from 0.34 (Mar 24) to 0.40, marking an increase of 0.06.
• For PBT Margin (%), as of Mar 25, the value is -1.99. This value is below the healthy minimum of 10. It has decreased from -1.65 (Mar 24) to -1.99, marking a decrease of 0.34.
• For Net Profit Margin (%), as of Mar 25, the value is -2.24. This value is below the healthy minimum of 5. It has decreased from -1.86 (Mar 24) to -2.24, marking a decrease of 0.38.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -2.24. This value is below the healthy minimum of 8. It has decreased from -1.86 (Mar 24) to -2.24, marking a decrease of 0.38.
• For Return on Networth / Equity (%), as of Mar 25, the value is -3.98. This value is below the healthy minimum of 15. It has decreased from -3.38 (Mar 24) to -3.98, marking a decrease of 0.60.
• For Return on Capital Employeed (%), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 10. It has decreased from 0.31 (Mar 24) to 0.28, marking a decrease of 0.03.
• For Return On Assets (%), as of Mar 25, the value is -1.21. This value is below the healthy minimum of 5. It has decreased from -1.16 (Mar 24) to -1.21, marking a decrease of 0.05.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 1.21. This value exceeds the healthy maximum of 1. It has increased from 0.70 (Mar 24) to 1.21, marking an increase of 0.51.
• For Total Debt / Equity (X), as of Mar 25, the value is 1.48. This value exceeds the healthy maximum of 1. It has increased from 1.01 (Mar 24) to 1.48, marking an increase of 0.47.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.57. It has decreased from 0.73 (Mar 24) to 0.57, marking a decrease of 0.16.
• For Current Ratio (X), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 1.5. It has decreased from 1.10 (Mar 24) to 1.04, marking a decrease of 0.06.
• For Quick Ratio (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.77, marking a decrease of 0.08.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.23. This value is within the healthy range. It has increased from 5.86 (Mar 24) to 6.23, marking an increase of 0.37.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -39.59 (Mar 24) to 0.00, marking an increase of 39.59.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 62.92 (Mar 24) to 0.00, marking a decrease of 62.92.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 139.59 (Mar 24) to 0.00, marking a decrease of 139.59.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 37.08 (Mar 24) to 0.00, marking a decrease of 37.08.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.41. This value is below the healthy minimum of 3. It has decreased from 1.69 (Mar 24) to 1.41, marking a decrease of 0.28.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.06. This value is below the healthy minimum of 3. It has decreased from 0.07 (Mar 24) to 0.06, marking a decrease of 0.01.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,836.01. It has increased from 2,961.10 (Mar 24) to 3,836.01, marking an increase of 874.91.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.87. This value is within the healthy range. It has increased from 1.42 (Mar 24) to 1.87, marking an increase of 0.45.
• For EV / EBITDA (X), as of Mar 25, the value is 55.27. This value exceeds the healthy maximum of 15. It has increased from 42.09 (Mar 24) to 55.27, marking an increase of 13.18.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 139.59 (Mar 24) to 0.00, marking a decrease of 139.59.
• For Price / BV (X), as of Mar 25, the value is 2.15. This value is within the healthy range. It has increased from 2.09 (Mar 24) to 2.15, marking an increase of 0.06.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has increased from 1.15 (Mar 24) to 1.21, marking an increase of 0.06.
• For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded -0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness